Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multicentric Prospective Cohort Study

María B. Arriaga, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, Betânia Nogueira, Maria Vitória C.N.S. Freire, Artur T.L. Queiroz, Moreno M.S. Rodrigues, Michael S. Rocha, Alexandra B. Souza, Renata Spener-Gomes, Anna Cristina C. Carvalho, Marina C. Figueiredo, Megan M. Turner, Betina Durovni, José R. Lapa-e-Silva, Afrânio L. Kritski, Solange Cavalcante, Valeria C. Rolla, Marcelo Cordeiro-Santos, Timothy R. Sterling, View ORCID ProfileBruno B. Andrade
doi: https://doi.org/10.1101/2021.03.15.21253595
María B. Arriaga
1Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
3Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mariana Araújo-Pereira
1Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
3Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Beatriz Barreto-Duarte
1Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
4Curso de Medicina, Universidade Salvador (UNIFACS), Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betânia Nogueira
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
3Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil
5Instituto Brasileiro para Investigação da Tuberculose, Fundação José Silveira, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Vitória C.N.S. Freire
6Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Artur T.L. Queiroz
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
7Center of Data and Knowledge Integration for Health (CIDACS), Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Moreno M.S. Rodrigues
8Laboratório de Análise e Visualização de Dados, Fundação Oswaldo Cruz, Porto Velho, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael S. Rocha
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
5Instituto Brasileiro para Investigação da Tuberculose, Fundação José Silveira, Salvador, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra B. Souza
9Fundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil
10Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Renata Spener-Gomes
9Fundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil
10Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil
11Universidade Federal do Amazonas, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna Cristina C. Carvalho
12Programa Acadêmico de Tuberculose da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
13Laboratório de Inovações em Terapias, Ensino e Bioprodutos (LITEB), Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina C. Figueiredo
14Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Megan M. Turner
14Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Betina Durovni
15Secretaria Municipal de Saúde do Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José R. Lapa-e-Silva
12Programa Acadêmico de Tuberculose da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Afrânio L. Kritski
12Programa Acadêmico de Tuberculose da Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Solange Cavalcante
15Secretaria Municipal de Saúde do Rio de Janeiro, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Valeria C. Rolla
16Laboratório de Pesquisa Clínica em Micobacteriose, Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Rio de Janeiro, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcelo Cordeiro-Santos
9Fundação Medicina Tropical Dr Heitor Vieira Dourado, Manaus, Brazil
10Programa de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil
17Universidade Nilton Lins, Manaus, Brazil
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy R. Sterling
14Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bruno B. Andrade
1Laboratório de Inflamação e Biomarcadores, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brazil
2Multinational Organization Network Sponsoring Translational and Epidemiological Research (MONSTER) Initiative, Salvador, Brazil
3Faculdade de Medicina, Universidade Federal da Bahia, Salvador, Brazil
4Curso de Medicina, Universidade Salvador (UNIFACS), Salvador, Brazil
6Curso de Medicina, Escola Bahiana de Medicina e Saúde Pública (EBMSP), Salvador, Brazil
14Division of Infectious Diseases, Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Bruno B. Andrade
  • For correspondence: bruno.andrade@fiocruz.br
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Background It is unclear whether diabetes or prediabetes drives adverse treatment outcomes and death in people with tuberculosis (PWTB).

Methods Culture-confirmed PWTB, enrolled in the Regional Prospective Observational Research in Tuberculosis (RePORT)-Brazil cohort between 2015 and 2019 (n=756) were stratified based on glycemic status by baseline glycated hemoglobin levels. Unfavorable TB outcome was defined as treatment failure or modification, recurrence or death, whereas favorable outcome was cure or treatment completion. We validated the findings using data from PWTB reported to the Brazilian National System of Diseases Notification (SINAN) during 2015-2019 (n=20,989). Stepwise binary multivariable regression analysis models evaluated associations between glycemic status and unfavorable outcomes.

Results In both cohorts, in univariate analysis, unfavorable outcomes were more frequently associated with drug resistance and HIV infection. Diabetes was associated with unfavorable outcomes in the RePORT (aOR: 2.85, p=0.001) and in SINAN (aOR: 1.56, p=0.040) cohorts. Furthermore, diabetes was associated with higher risk of death in both, RePORT-Brazil (aOR:3.23, p=0.006) and in the SINAN (aOR:2.75, p= 0.047) cohorts.

Conclusion Diabetes was associated with an increased risk of unfavorable outcomes and mortality in Brazilian PWTB. Interventions to improve tuberculosis treatment outcomes in persons with diabetes are needed.

40-word summary of the article’s main point In a multicenter prospective cohort study from Brazil, diabetes was associated with an increased risk of unfavorable treatment outcomes, including mortality, in pulmonary tuberculosis patients. These observations were validated in the Brazilian National Disease Notification System during the same period.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The study was supported by the Intramural Research Program of the Fundacao Oswaldo Cruz, Intramural Research Program of the Fundacao Jose Silveira, Departamento de Ciencia e Tecnologia (DECIT), Secretaria de Ciencia e Tecnologia (SCTIE), Ministerio da Saude (MS), Brazil [25029.000507/2013.07] and the National Institutes of Allergy and Infectious Diseases [U01AI069923]. M.B.A. received a fellowship from the Fundacao de Amparo a Pesquisa da Bahia (FAPESB). M.A.-P. received a fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Finance code: 001). B.B.A., J.R.L.S. and A.K. are senior investigators of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Brazil.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was conducted according to the principles in the Declaration of Helsinki. The RePORT-Brazil protocol was approved by the institutional review boards at each study site and at Vanderbilt University Medical Center. The protocol, informed consent, and study documents were approved by the institutional review boards at all study sites. The Institional Review Boards and the protocol approval numbers are as follows: (i) Instituto de Pesquisa Clínica Evandro Chagas, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil (protocol no. 688.067), (ii) Secretaria Municipal de Saude do Rio de Janeiro, Brazil (protocol no. 740.554), (iii) Hospital Universitario Clementino Fraga Filho Rio de Janeiro, Brazil (protocol no. 852.519), (iv) Maternidade Climério de Oliveira, Universidade Federal da Bahia, Salvador, Brazil (protocol no. 723.168), (v) Fundação de Medicina Tropical Dr. Heitor Vieira Dourado, Manaus, Brazil (protocol no. 807.595). Participation was voluntary and written informed consent was obtained from all participants. Participation in RePORT-Brazil was voluntary, and written informed consent was obtained from all participants. All data extracted from SINAN were public and freely accessible. The anonymity of study subjects was preserved; all data were de-identified.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data extracted from SINAN are public and freely accessible (http://www.portalsinan.saude.gov.br/dados-epidemiologicos-sinan). The data from RePORT Brazil can be available upon reasonable request to the corresponding author.

http://www.portalsinan.saude.gov.br/dados-epidemiologicos-sinan

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 24, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multicentric Prospective Cohort Study
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multicentric Prospective Cohort Study
María B. Arriaga, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, Betânia Nogueira, Maria Vitória C.N.S. Freire, Artur T.L. Queiroz, Moreno M.S. Rodrigues, Michael S. Rocha, Alexandra B. Souza, Renata Spener-Gomes, Anna Cristina C. Carvalho, Marina C. Figueiredo, Megan M. Turner, Betina Durovni, José R. Lapa-e-Silva, Afrânio L. Kritski, Solange Cavalcante, Valeria C. Rolla, Marcelo Cordeiro-Santos, Timothy R. Sterling, Bruno B. Andrade
medRxiv 2021.03.15.21253595; doi: https://doi.org/10.1101/2021.03.15.21253595
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multicentric Prospective Cohort Study
María B. Arriaga, Mariana Araújo-Pereira, Beatriz Barreto-Duarte, Betânia Nogueira, Maria Vitória C.N.S. Freire, Artur T.L. Queiroz, Moreno M.S. Rodrigues, Michael S. Rocha, Alexandra B. Souza, Renata Spener-Gomes, Anna Cristina C. Carvalho, Marina C. Figueiredo, Megan M. Turner, Betina Durovni, José R. Lapa-e-Silva, Afrânio L. Kritski, Solange Cavalcante, Valeria C. Rolla, Marcelo Cordeiro-Santos, Timothy R. Sterling, Bruno B. Andrade
medRxiv 2021.03.15.21253595; doi: https://doi.org/10.1101/2021.03.15.21253595

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (179)
  • Allergy and Immunology (431)
  • Anesthesia (99)
  • Cardiovascular Medicine (943)
  • Dentistry and Oral Medicine (178)
  • Dermatology (109)
  • Emergency Medicine (260)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (419)
  • Epidemiology (8971)
  • Forensic Medicine (4)
  • Gastroenterology (418)
  • Genetic and Genomic Medicine (1938)
  • Geriatric Medicine (190)
  • Health Economics (400)
  • Health Informatics (1323)
  • Health Policy (657)
  • Health Systems and Quality Improvement (517)
  • Hematology (212)
  • HIV/AIDS (416)
  • Infectious Diseases (except HIV/AIDS) (10772)
  • Intensive Care and Critical Care Medicine (571)
  • Medical Education (200)
  • Medical Ethics (54)
  • Nephrology (221)
  • Neurology (1819)
  • Nursing (108)
  • Nutrition (271)
  • Obstetrics and Gynecology (351)
  • Occupational and Environmental Health (469)
  • Oncology (992)
  • Ophthalmology (296)
  • Orthopedics (111)
  • Otolaryngology (182)
  • Pain Medicine (126)
  • Palliative Medicine (44)
  • Pathology (265)
  • Pediatrics (576)
  • Pharmacology and Therapeutics (275)
  • Primary Care Research (234)
  • Psychiatry and Clinical Psychology (1892)
  • Public and Global Health (4111)
  • Radiology and Imaging (674)
  • Rehabilitation Medicine and Physical Therapy (364)
  • Respiratory Medicine (548)
  • Rheumatology (224)
  • Sexual and Reproductive Health (190)
  • Sports Medicine (177)
  • Surgery (207)
  • Toxicology (38)
  • Transplantation (109)
  • Urology (80)